中外製薬part21

[660 名無しさん＠お腹いっぱい。 2025/03/12(水) 22:40:32.61]

Wearable Device Outcomes From EMBARK, a Pivotal Phase 3 Study in Patients With Duchenne Muscular Dystrophy Treated With Delandistrogene Moxeparvovec